Targeted Action and Financing the Fight Against Antimicrobial Resistance in Asia 2025

Images: Getty Images Disclaimer This document is published by the World Economic Forum as a contribution to a project, insight area or interaction. The findings, interpretations and conclusions expressed herein are a result of a collaborative process facilitated and endorsed by the World Economic Forum but whose results do not necessarily represent the views of the World Economic Forum, nor the entirety of its Members, Partners or other stakeholders. © 2025 World Economic Forum. All rights reserved. No part of this publication may be reproduced or transmitted in any form or by any means, including photocopying and recording, or by any information storage and retrieval system.Contents Foreword 3 Executive summary 4 1 The global threat of antimicrobial resistance 5 1.1 The scale of the crisis 5 1.2 The background 5 1.3 Not just a health issue 7 1.4 Market failures and economic impact 8 1.5 The impact of climate change 8 1.6 The global response 9 2 Asia: The perfect crucible for AMR 11 2.1 The scale of the problem 11 2.2 Asia’s rapidly changing demographics 13 2.3 The factors influencing AMR in Asia 15 2.4 An urgent call to action 19 3 Supercharging the fight against superbugs 20 3.1 Opportunities ripe for capitalizing 20 Conclusion 40 Contributors 41 Endnotes 43 2 Targeted Action and Financing the Fight Against Antimicrobial Resistance in Asia